Skip to main content
New Microbes and New Infections logoLink to New Microbes and New Infections
letter
. 2015 Sep 10;8:17–18. doi: 10.1016/j.nmni.2015.09.002

First report of NDM-5-producing Escherichia coli ST1284 isolated from dog in Bejaia, Algeria

M Yousfi 1, A Mairi 1, S Bakour 1,2, A Touati 1,, L Hassissen 1, L Hadjadj 2, J-M Rolain 2
PMCID: PMC4600852  PMID: 26566444

Carbapenemase-producing isolates have been isolated from humans, environmental samples and, more recently, companion animals [1]. Among the newly emerged carbapenemases, New Delhi metallo-β-lactamase (NDM) represents the latest threat for public health [2]. Sixteen variants of NDM-type carbapenemase (NDM-1 to NDM-16) have been reported (http://www.lahey.org/Studies).

Here we report what is to our knowledge the first case of Escherichia coli carrying the blaNDM-5 gene isolated from a dog in Algeria.

In March 2015 a rectal swab was collected from a 3-year-old German Shepherd dog with a tumor at its third finger. The sample was cultured in 10 mL nutrient broth containing half a disc of ertapenem. After incubation at 37°C for 24 hours, 200 μL was streaked on MacConkey agar plates containing imipenem at a concentration of 0.5 μg/mL. An Escherichia coli isolate was identified by MALDI-TOF (matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; Microflex, Bruker Daltonics, Bremen, Germany). Antibiotic susceptibility testing was performed by the disk diffusion method and interpreted according to the European Committee on Antimicrobial Susceptibility Testing guidelines (http://www.eucast.org/). The minimum inhibitory concentration (MIC) values of β-lactams were determined using Etest strips according to the manufacturer's recommendations (AB bioMérieux, Solna, Sweden).

The E. coli isolate was found resistant to β-lactams, including carbapenems (MICs >32 μg/mL) and extended-spectrum cephalosporins (MICs >256 μg/mL). The isolate was also resistant to tetracycline and fluoroquinolones but was susceptible to amikacin, cotrimoxazole, colistin and tigecycline.

The isolate was screened for carbapenemase production using the modified Carba NP test [3], and the production of metallo-β-lactamases was detected by the inhibition of the metallo-β-lactamase activity by ethylenediaminetetraacetic acid (EDTA) as previously described [4]. The E. coli isolate was positive for production of carbapenemase, which is inhibited by EDTA.

PCR was used to screen for the presence of genes encoding for class A carbapenemases (blaKPC and blaGES), class D carbapenemases (blaOXA-48) and metallo-β-lactamases (blaNDM-1 and blaVIM) as previously described [5], followed by sequencing, which led to the identification of blaNDM-5. A review the literature at PubMed found 12 reports on NDM-5, which were all recovered from clinical specimens; no reports were from veterinary isolates, however. Among these 12 reports, one was from Algeria [6]. The authors of this study reported three isolates of E. coli sequence type (ST) 2659 recovered from urine and blood specimen isolated between January 2012 and February 2013 in the university hospital of Annaba (east Algeria). Thus, this is the first report of NDM-5-producing E. coli isolated from companion animals. Furthermore, other types of carbapenemases have been reported from domesticated animals, including NDM-1 in multidrug-resistant E. coli strains recovered from companion animals in the United States [7], and OXA-48 carbapenemase-producing Klebsiella pneumoniae and E. coli isolates obtained from a dog in Germany [8]. The E. coli isolate also carried the blaTEM-33 gene.

The transferability of the resistance phenotype was studied by a conjugation experiment using sodium azide–resistant E. coli strain J53 as a recipient. The transconjugants were selected on Luria agar plates containing ceftazidime (8 μg/mL) and sodium azide (200 μg/mL) [2]. Only transconjugants carrying the blaTEM-33 gene were obtained. To determine the localization of the blaNDM-5 gene the isolate was subjected to plasmid extraction using the High Purity Plasmid Miniprep Kit (Neobiotech, Los Angeles, CA, USA) and the QIAquick Gel extraction kit (Qiagen, Germantown, MD, USA), followed by PCR amplification targeting blaNDM-5 performed on the extracted plasmid. The result showed that the isolate harboured only one plasmid which did not contain the blaNDM-5 gene, indicating that this gene is probably integrated into the chromosome.

Genotyping of the isolate was performed by multilocus sequence typing (MLST) using seven housekeeping genes (adk, fumC, gyrB, icd, mdh, purA and recA), as described at the E. coli MLST Database (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). According to MLST analysis, the E. coli isolate was attributed to ST1284. This ST has been identified previously in E. coli isolates producing extended-spectrum β-lactamase recovered from animals [9].

In summary, this report documents the emergence of NDM-5 among E. coli ST1284 isolated for the first time from a companion animal in the North African countries.

Conflict of interest

None declared.

References

  • 1.Szmolka A., Nagy B. Multidrug resistant commensal Escherichia coli in animals and its impact for public health. Front Microbiol. 2013;4:258. doi: 10.3389/fmicb.2013.00258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Yong D., Toleman M.A., Giske C.G., Cho H.S., Sundman K., Lee K. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:5046–5054. doi: 10.1128/AAC.00774-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bakour S., Garcia V., Loucif L., Brunel J.M., Gharout-Sait A., Touati A. Rapid identification of carbapenemase-producing Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii using a modified Carba NP test. New Microbes New Infect. 2015;7:89–93. doi: 10.1016/j.nmni.2015.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Yong D., Lee K., Yum J.H., Shin H.B., Rossolini G.M., Chong Y. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2002;40:3798–3801. doi: 10.1128/JCM.40.10.3798-3801.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bakour S., Sahli F., Touati A., Rolain J.M. Emergence of KPC-producing Klebsiella pneumoniae ST512 isolated from cerebrospinal fluid of a child in Algeria. New Microbes New Infect. 2015;3:34–36. doi: 10.1016/j.nmni.2014.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Sassi A., Loucif L., Gupta S.K., Dekhil M., Chettibi H., Rolain J.M. NDM-5 carbapenemase-encoding gene in multidrug-resistant clinical isolates of Escherichia coli from Algeria. Antimicrob Agents Chemother. 2014;58:5606–5608. doi: 10.1128/AAC.02818-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Shaheen B.W., Nayak R., Boothe D.M. Emergence of a New Delhi metallo-β-lactamase (NDM-1)-encoding gene in clinical Escherichia coli isolates recovered from companion animals in the United States. Antimicrob Agents Chemother. 2013;57:2902–2903. doi: 10.1128/AAC.02028-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Stolle I., Prenger-Berninghoff E., Stamm I., Scheufen S., Hassdenteufel E., Guenther S. Emergence of OXA-48 carbapenemase-producing and Escherichia coli Klebsiella pneumoniae in dogs. J Antimicrob Chemother. 2013;68:2802–2808. doi: 10.1093/jac/dkt259. [DOI] [PubMed] [Google Scholar]
  • 9.Wu G., Day M.J., Mafura M.T., Nunez-Garcia J., Fenner J.J., Sharma M. Comparative analysis of ESBL-positive Escherichia coli isolates from animals and humans from the UK, The Netherlands and Germany. PLoS One. 2013;8:e75392. doi: 10.1371/journal.pone.0075392. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from New Microbes and New Infections are provided here courtesy of Elsevier

RESOURCES